How Ligands Illuminate GPCR Molecular Pharmacology

Publication date: 27 July 2017
Source:Cell, Volume 170, Issue 3
Author(s): Daniel Wacker, Raymond C. Stevens, Bryan L. Roth
G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome. Recent structural and molecular studies have both transformed and expanded classical concepts of receptor pharmacology and have begun to illuminate the distinct mechanisms by which structurally, chemically, and functionally diverse ligands modulate GPCR function. These molecular insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compounds, especially for understudied and orphan GPCRs. These advances promise to streamline the development of GPCR-targeted medications.

Teaser

Structural and computational approaches studying GPCR-ligand interactions are shaping fundamental principles in receptor signaling and uncovering new physiological functions for this protein family.


from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vPmIjF
via IFTTT